Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, LYONS GARY A, holds the title of Director at NEUROCRINE BIOSCIENCES INC.
On 2026-11-17, the insider transacted 30,000 shares.The shares were transacted at a weighted average price of $109.25 per share, resulting in a total market-relevant value of $3.3M.
LYONS GARY A (Director) sold $3.3M of $NBIX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.